Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Sidis, Yisrael

Class:IdPerson:2473159
_displayNameSidis, Yisrael
_timestamp2012-09-21 21:31:11
created[InstanceEdit:2473197] May, B, 2012-09-21
firstnameYisrael
initialY
surnameSidis
(author)[LiteratureReference:2473157] Differential actions of follistatin and follistatin-like 3
[LiteratureReference:2473177] FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults
[LiteratureReference:2473179] Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG)
[LiteratureReference:2473192] Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3
[LiteratureReference:2473210] The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity
[LiteratureReference:2473214] Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin
[LiteratureReference:8858598] Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
[LiteratureReference:8858601] Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4
[LiteratureReference:8858604] Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
[LiteratureReference:8858641] DRAGON, a bone morphogenetic protein co-receptor
List all 11 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Sidis, Yisrael (2473159)